Technical Analyst, Deepak Mohoni is of the opinion that Dr Reddy's Laboratories is a better pick than Ranbaxy Laboratories or Cipla.

Mohoni told CNBC-TV18, "Glenmark, Orchid have been making fairly good moves, they didn’t have such a good day yesterday. Biocon is another one, which for a change is leading the pharma pack. So I think these 3 stocks they have a little bit of momentum going for them. Reddy’s among the bigger ones perhaps could be a better pick than Ranbaxy or Cipla."